razoxane has been researched along with Cardiovascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, M; Kim, KI; Oh, JM; Shin, WG; Song, YC | 1 |
| Champion, C; Durand, JB; Ewer, MS; Gibbs, H; Lenihan, DJ; Swafford, J; Tong, AT; Yeh, ET; Yusuf, SW; Zafarmand, AA | 1 |
| Cvetković, RS; Scott, LJ | 1 |
| Huang, X; Katz, SD; Zhang, Q; Zheng, H | 1 |
| Sullivan, JL | 1 |
| Steinherz, L | 1 |
| Anandasbapathy, S; Elihu, N; Frishman, WH | 1 |
3 review(s) available for razoxane and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Topics: Anthracyclines; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biomarkers; Biopsy; Cardiovascular Diseases; Cytokines; Heart; Humans; Neoplasms; Pericardium; Radiation Injuries; Radiotherapy; Razoxane; Risk Factors | 2004 |
Dexrazoxane : a review of its use for cardioprotection during anthracycline chemotherapy.
Topics: Anthracyclines; Antineoplastic Agents; Cardiovascular Agents; Cardiovascular Diseases; Humans; Neoplasms; Randomized Controlled Trials as Topic; Razoxane | 2005 |
Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
Topics: Antibiotics, Antineoplastic; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Deferoxamine; Doxorubicin; Edetic Acid; Female; Humans; Iron; Razoxane | 1998 |
1 trial(s) available for razoxane and Cardiovascular Diseases
| Article | Year |
|---|---|
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation | 2006 |
3 other study(ies) available for razoxane and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardioprotective effect of early dexrazoxane use in anthracycline treated pediatric patients.
Topics: Adolescent; Age Factors; Anthracyclines; Cardiovascular Agents; Cardiovascular Diseases; Child; Child, Preschool; Female; Heart Function Tests; Hospitals, Teaching; Humans; Infant; Male; Neoplasms; Razoxane; Republic of Korea; Retrospective Studies | 2012 |
Is homocysteine an iron-dependent cardiovascular risk factor?
Topics: Adult; Cardiovascular Diseases; Chelating Agents; Endothelium, Vascular; Female; Ferritins; Homocysteine; Humans; Iron; Iron Deficiencies; Male; Methionine; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Sex Characteristics; Vasodilation | 2006 |
Early breast cancer therapy and cardiovascular injury.
Topics: Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotonic Agents; Cardiovascular Diseases; Female; Humans; Razoxane; Treatment Outcome | 2008 |